Equity Profile

LIVN

LivaNova PLC

Health CareHealth Care Equipment$4.0B

May6Wed

Post-Earnings Recap

ReportedQ1-2026Pre-Market6:00 AM EDT

LivaNova PLC Beats on EPS, Stock Up 15.05%

Metric	Actual	Expected	Surprise
EPS	$0.98	$0.90	+36.11%
Revenue	N/A	$346M	N/A

management commentary, guidance changes, and full analysis available with Pro.

LivaNova PLC Beats on EPS, Stock Up 15.05%

Key Numbers

Metric	Actual	Expected	Surprise
EPS	$0.98	$0.90	+36.11%
Revenue	N/A	$346M	N/A

Management Commentary

Tone: Unknown

No transcript is on record, so the analysis is based solely on numerical results.

What It Means

LivaNova's strong earnings per share performance exceeded expectations, which likely contributed to the stock's significant increase of 15.05% in response. However, the lack of revenue details and management commentary leaves some uncertainty about overall performance and future direction. Investors may want to watch for more information in upcoming reports.

Company Snapshot

LivaNova PLC is a health care company specializing in medical devices and therapies. With a market cap of $3 billion, it plays a crucial role in the health care equipment sector, focusing on innovative solutions that improve patient outcomes.

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and can influence investor sentiment.

$0.90

Revenue

Revenue figures provide insight into the company's sales performance and overall market demand.

$346M

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+39.47%

Avg Stock Reaction

+2.92%

Last Quarter Recap

In Q4 2025, LivaNova reported an EPS of $0.86, beating expectations by 28.94%. The stock reacted positively, gaining 1.80% the following day.

Management Promises & Guidance

Continued focus on innovation in medical devices.
Commitment to improving operational efficiency.
Plans to expand into new markets.

Expectations

Wall Street Expectations

Analysts expect LivaNova to report solid earnings this quarter, with a consensus EPS of $0.90 and revenue of $346 million. Investors are keen to see if the company can maintain its strong performance.

Bull Case

If LivaNova exceeds EPS estimates, it could signal robust demand for its products and lead to a positive stock reaction, continuing its trend of beating earnings expectations.

Bear Case

Conversely, if the company misses EPS or revenue estimates, it may raise concerns about its growth trajectory and market competitiveness, potentially leading to a negative stock reaction.

Key Metrics to Watch

EPS

$0.90

Earnings per share is a key indicator of profitability and can influence investor sentiment.

Revenue

$346M

Revenue figures provide insight into the company's sales performance and overall market demand.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will LivaNova's EPS exceed the consensus estimate of $0.90?

A beat on EPS could reinforce investor confidence and support a positive stock reaction.

What is the revenue outlook for the upcoming quarters?

Revenue guidance will be critical in assessing the company's growth potential and market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate LivaNova's ability to leverage recent product innovations, which could drive higher-than-expected revenue growth.

Supporting Evidence

LivaNova has consistently beaten EPS estimates in recent quarters, indicating strong operational execution.

The options market is pricing a larger move than historical averages, suggesting potential for a significant surprise.

Key Risk

If revenue growth exceeds $351 million, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating LivaNova's ability to sustain its growth trajectory amidst competitive pressures.

Bull Confirmed If

An EPS of $1.03 or higher would confirm strong operational performance.

Bear Confirmed If

An EPS below $0.75 would raise concerns about profitability and market demand.

Pre-Earnings Positioning

Options Market

Implied Move

±12.48%

Historical Avg

±10.0%

Pricing rich

The options market is pricing in a significant potential move, indicating that investors expect volatility around the earnings announcement.

Options are pricing ±12.2% while LIVN has averaged ±10.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.8%

30d HV

32.0%

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: X of Y (Z%)

This setup has occurred 30 times across Health Care in the last 2 years. The average absolute 1-day move is 4.1%, with a raw directional average of +1.7% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If LivaNova beats expectations, history suggests the stock could rise by an average of 2.58%, confirming strong demand.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a significant drop, with historical patterns indicating a potential decline based on past reactions.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on sales.
2Management's commentary on market conditions and competitive landscape.
3Insights into operational efficiencies and cost management strategies.
4Guidance on revenue expectations for the next quarter.
5Details on geographic expansion plans and their potential revenue contributions.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

May4

GRABReported

Grab Holdings Limited

RecapView

May4

GBDCReported

Company Snapshot

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and can influence investor sentiment.

$0.90

Revenue

Revenue figures provide insight into the company's sales performance and overall market demand.

$346M

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+39.47%

Avg Stock Reaction

+2.92%

Last Quarter Recap

In Q4 2025, LivaNova reported an EPS of $0.86, beating expectations by 28.94%. The stock reacted positively, gaining 1.80% the following day.

Management Promises & Guidance

Continued focus on innovation in medical devices.
Commitment to improving operational efficiency.
Plans to expand into new markets.

Expectations

Wall Street Expectations

Bull Case

If LivaNova exceeds EPS estimates, it could signal robust demand for its products and lead to a positive stock reaction, continuing its trend of beating earnings expectations.

Bear Case

Conversely, if the company misses EPS or revenue estimates, it may raise concerns about its growth trajectory and market competitiveness, potentially leading to a negative stock reaction.

Key Metrics to Watch

EPS

$0.90

Earnings per share is a key indicator of profitability and can influence investor sentiment.

Revenue

$346M

Revenue figures provide insight into the company's sales performance and overall market demand.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will LivaNova's EPS exceed the consensus estimate of $0.90?

A beat on EPS could reinforce investor confidence and support a positive stock reaction.

What is the revenue outlook for the upcoming quarters?

Revenue guidance will be critical in assessing the company's growth potential and market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate LivaNova's ability to leverage recent product innovations, which could drive higher-than-expected revenue growth.

Supporting Evidence

LivaNova has consistently beaten EPS estimates in recent quarters, indicating strong operational execution.

The options market is pricing a larger move than historical averages, suggesting potential for a significant surprise.

Key Risk

If revenue growth exceeds $351 million, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating LivaNova's ability to sustain its growth trajectory amidst competitive pressures.

Bull Confirmed If

An EPS of $1.03 or higher would confirm strong operational performance.

Bear Confirmed If

An EPS below $0.75 would raise concerns about profitability and market demand.

Pre-Earnings Positioning

Options Market

Implied Move

±12.48%

Historical Avg

±10.0%

Pricing rich

The options market is pricing in a significant potential move, indicating that investors expect volatility around the earnings announcement.

Options are pricing ±12.2% while LIVN has averaged ±10.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.8%

30d HV

32.0%

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: X of Y (Z%)

This setup has occurred 30 times across Health Care in the last 2 years. The average absolute 1-day move is 4.1%, with a raw directional average of +1.7% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If LivaNova beats expectations, history suggests the stock could rise by an average of 2.58%, confirming strong demand.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a significant drop, with historical patterns indicating a potential decline based on past reactions.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on sales.
2Management's commentary on market conditions and competitive landscape.
3Insights into operational efficiencies and cost management strategies.
4Guidance on revenue expectations for the next quarter.
5Details on geographic expansion plans and their potential revenue contributions.